GOTTINGEN, GERMANY - March 16, 2026 (NEWMEDIAWIRE) - The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies. The ...
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, and Repligen Corporation, a global life sciences company focused on bioprocessing technologies, ...
Collaboration to combine the Waters™ BioAccord™ LC-MS System as a bioprocess analyzer with the Sartorius Ambr ® bioreactor system gives bioprocess scientists both faster and direct access to advanced ...
CultiFlask 50 disposable bioreactors from Sartorius offer a fast and economical approach for performing many parallel cell cultivation experiments. Being superior to tissue culture flasks in maximum ...
New expandable benchtop workstation with unique single-use bioreactor design offers a simple approach to process development for fermentation and cell culture Sartorius Stedim Biotech (SSB) introduced ...
Sartorius AG is a pure play in the bioprocessing industry, dominating the single-use bioreactors market with a focus on upstream flow. Sartorius' strong customer relationships and service-first ...
The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies. The modular Eveo Cell Therapy Platform is designed to ...
GOTTINGEN, GERMANY / ACCESS Newswire / March 16, 2026 / Sartorius launches next-generation platform to boost efficiency in cell therapy production Eveo Cell Therapy Platform enables automated, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results